Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Available NCT03773770

Expanded Access to Triheptanoin

Conditions: Long Chain Fatty Acid Oxidation Disorders

Sex: All
Sponsor: Ultragenyx Pharmaceutical Inc

Summary

Expanded access may be provided for qualified patients who have limited treatment options and are not eligible for a clinical trial.

Eligibility Criteria

\- The participant must not be eligible for a UX007 clinical trial

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT03773770). StuddyBuddy aggregates publicly available trial information.